STOCK TITAN
  1. Home
  2. News
  3. RYTM

Rhythm Pharmaceuticals Inc. - RYTM STOCK NEWS

IMPACT
SENTIMENT
RYTM : Nasdaq
Rhythm Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide) for Patients with Bardet-Biedl Syndrome and Alström Syndrome
IMPACT
SENTIMENT
RYTM : Nasdaq
Rhythm Pharmaceuticals to Present at Stifel 2021 Virtual Healthcare Conference
conferences
IMPACT
SENTIMENT
RYTM : Nasdaq
Rhythm Pharmaceuticals Reports Third Quarter 2021 Financial Results
earnings
IMPACT
SENTIMENT
RYTM : Nasdaq
Rhythm Pharmaceuticals Presents First-ever Data Showing Improvements in Health-related Quality of Life for Patients Living with Bardet-Biedl Syndrome at ObesityWeek® 2021
IMPACT
SENTIMENT
RYTM : Nasdaq
Rhythm Pharmaceuticals to Report Third Quarter 2021 Financial Results on Tuesday, November 2, 2021
conferences earnings
IMPACT
SENTIMENT
RYTM : Nasdaq
Rhythm Pharmaceuticals Completes Submission of Type II Variation Application to the European Medicines Agency for IMCIVREE® (setmelanotide) for Bardet-Biedl and Alström Syndromes
IMPACT
SENTIMENT
RYTM : Nasdaq
Rhythm Pharmaceuticals Presents New Data on Experience of People Living with Rare Genetic Diseases of Obesity and Provides Updates on Uncovering Rare Obesity® Genetic Testing Program
IMPACT
SENTIMENT
RYTM : Nasdaq
Rhythm Pharmaceuticals Presents New Data from Phase 2 and 3 Trials Evaluating Setmelanotide in Multiple Rare Genetic Diseases of Obesity at the 59th Annual ESPE Meeting
clinical trial
IMPACT
SENTIMENT
RYTM : Nasdaq
Rhythm Pharmaceuticals Announces Marketing Authorisation of IMCIVREE® (setmelanotide) in Great Britain
IMPACT
SENTIMENT
RYTM : Nasdaq
Rhythm Pharmaceuticals Completes Submission of Supplemental New Drug Application to U.S. Food and Drug Administration for IMCIVREE® (setmelanotide) for the treatment of obesity and control of hunger in Bardet-Biedl and Alström Syndromes
Stock RYTM logo
Rhythm Pharmaceuticals Inc.

Nasdaq:RYTM

RYTM Rankings

#2279 Ranked by Market Cap
#2878 Ranked by Stock Gains
N/A Ranked by Dividends

RYTM Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Boston

About RYTM

rhythm pharmaceuticals inc. is a biotechnology company located in 855 boylston street, 11th floor, boston, ma, united states.